Patient preferences concerning the efficacy and side-effect profile of schizophrenia medications: a survey of patients living with schizophrenia

被引:28
作者
Achtyes, Eric [1 ,2 ]
Simmons, Adam [3 ]
Skabeev, Anna [3 ]
Levy, Nikki [3 ]
Jiang, Ying [3 ]
Marcy, Patricia [4 ]
Weiden, Peter J. [3 ]
机构
[1] Cherry Hlth, Grand Rapids, MI USA
[2] Michigan State Univ, Coll Human Med, Grand Rapids, MI 49503 USA
[3] Alkermes Inc, Waltham, MA USA
[4] Northwell Hlth Syst, Vanguard Res Grp, Manhasset, NY USA
来源
BMC PSYCHIATRY | 2018年 / 18卷
关键词
Adherence; Antipsychotics; Weight; Side effects; PSYCHIATRY WFSBP GUIDELINES; BIOLOGICAL TREATMENT; ANTIPSYCHOTIC-DRUGS; REPORTED OUTCOMES; WORLD FEDERATION; UPDATE; 2012; MANAGEMENT; SOCIETIES;
D O I
10.1186/s12888-018-1856-y
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Background: Despite the availability of numerous antipsychotic medications, many patients with schizophrenia continue to experience side effects that contribute to the overall burden of the illness. The present survey of patients with schizophrenia and schizoaffective disorder aimed to assess patient attitudes toward antipsychotic treatment, and understand key factors about willingness to try a new medication. Methods: A cross-sectional survey was administered to 250 patients with a primary clinical diagnosis of a schizophrenia spectrum disorder across five outpatient clinics in the United States. The survey included self-reported gender, age, weight, and height, and questions about the importance of efficacy and side effects on the decision to take a prescribed antipsychotic medication. Results: Patients rated efficacy and side effects as important attributes of antipsychotic treatment, with 93.6% and 83.6% of patients listing these as "very" or the "most" important factors in taking prescribed medication. A total of 87.6% of respondents identified the ability to think more clearly as an important property of their medication. Patients identified weight gain, physical restlessness, and somnolence as important side effects of current treatments ("very" or "most" important by 61.6%, 60.8%, and 58.8%, respectively). When asked about willingness to change antipsychotic medication, anticipated weight gain had a negative influence on willingness to try the new treatment, with 22.0% declining to try a medication that would lead to weight gain of 2.7-4.5 kg (6-10 lb), 34.0% declining for anticipated weight gain of 5.0-9.1 kg (11-20 lb), and 52.4% declining for anticipated weight gain greater than 9 kg (20 lbs). Conclusion: Patients living with schizophrenia spectrum disorders are influenced by many factors when considering whether to take their medication, including efficacy and side effects. It is important for clinicians to assess specific patient concerns to develop a comprehensive treatment plan that maximizes adherence to the prescribed therapy.
引用
收藏
页数:7
相关论文
共 21 条
  • [1] Association Psychiatric Association, DIAGN STAT MAN MENT, P2013
  • [2] Patient-Reported Outcomes - Are They Living Up to Their Potential?
    Baumhauer, Judith F.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (01) : 6 - 9
  • [3] Causes of the excess mortality of schizophrenia
    Brown, S
    Inskip, H
    Barraclough, B
    [J]. BRITISH JOURNAL OF PSYCHIATRY, 2000, 177 : 212 - 217
  • [4] Antipsychotics for acute schizophrenia: making choices
    Correll, Christoph U.
    De Hert, Marc
    [J]. LANCET, 2013, 382 (9896) : 919 - 920
  • [5] Quantifying Clinical Relevance in the Treatment of Schizophrenia
    Correll, Christoph U.
    Kishimoto, Taishiro
    Nielsen, Jimmi
    Kane, John M.
    [J]. CLINICAL THERAPEUTICS, 2011, 33 (12) : B16 - B39
  • [6] Distress with medication side effects among persons with severe mental illness
    Covell, Nancy H.
    Weissman, Ellen M.
    Schell, Bonnie
    McCorkle, Brian H.
    Summerfelt, W. Thomas
    Weiden, Peter J.
    Essock, Susan M.
    [J]. ADMINISTRATION AND POLICY IN MENTAL HEALTH AND MENTAL HEALTH SERVICES RESEARCH, 2007, 34 (05) : 435 - 442
  • [7] A patient perspective of the impact of medication side effects on adherence: results of a cross-sectional nationwide survey of patients with schizophrenia
    DiBonaventura, Marco
    Gabriel, Susan
    Dupclay, Leon
    Gupta, Shaloo
    Kim, Edward
    [J]. BMC PSYCHIATRY, 2012, 12
  • [8] Perceived functioning, well-being and psychiatric symptoms in patients with stable schizophrenia treated with long-acting risperidone for 1 year
    Fleischhacker, WW
    Rabinowitz, J
    Kemmler, G
    Eerdekens, M
    Mehnert, A
    [J]. BRITISH JOURNAL OF PSYCHIATRY, 2005, 187 : 131 - 136
  • [9] World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 2: Update 2012 on the long-term treatment of schizophrenia and management of antipsychotic-induced side effects
    Hasan, Alkomiet
    Falkai, Peter
    Wobrock, Thomas
    Lieberman, Jeffrey
    Glenthoj, Birte
    Gattaz, Wagner F.
    Thibaut, Florence
    Moeller, Hans-Juergen
    [J]. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY, 2013, 14 (01) : 2 - 44
  • [10] World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 1: Update 2012 on the acute treatment of schizophrenia and the management of treatment resistance
    Hasan, Alkomiet
    Falkai, Peter
    Wobrock, Thomas
    Lieberman, Jeffrey
    Glenthoj, Birte
    Gattaz, Wagner F.
    Thibaut, Florence
    Moeller, Hans-Juergen
    [J]. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY, 2012, 13 (05) : 318 - 378